Vedrop
What Vedrop is used for
Vedrop is indicated in vitamin-E deficiency due to digestive malabsorption in paediatric patients suffering from congenital chronic cholestasis or hereditary chronic cholestasis, from birth (in term newborns) to 16 or 18 years of age, depending on the region.
Approved use, as published by the European Medicines Agency.
What the labels mean
- Approved under exceptional circumstances: full data cannot be collected, usually because the disease is very rare.
Key facts
- Brand
- Vedrop
- Active substance
- tocofersolan
- Disease area
- Cholestasis; Vitamin E Deficiency
- Medicine group
- Vitamins
- ATC code
- A11HA08
- Marketing authorisation holder
- Recordati Rare Diseases
- Authorised in the EU since
- 2009
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vedrop used for?
Vedrop is indicated in vitamin-E deficiency due to digestive malabsorption in paediatric patients suffering from congenital chronic cholestasis or hereditary chronic cholestasis, from birth (in term newborns) to 16 or 18 years of age, depending on the region.
What is the active substance in Vedrop?
Vedrop contains tocofersolan.
Who makes Vedrop?
The EU marketing authorisation holder is Recordati Rare Diseases.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU